Laboratory News and Research

RSS

Oral antiseptics and mouthwashes may have the ability to neutralize human coronavirus

Certain oral antiseptics and mouthwashes may have the ability to inactivate human coronaviruses, according to a Penn State College of Medicine research study.

19 Oct 2020

Health care groups dive into property tax ballot fight, eyeing public health money

A November ballot initiative to raise property taxes on big-business owners in California is drawing unconventional political support from health care power players and public health leaders.

19 Oct 2020

Novel multimodal intervention improves physical fitness and cognitive function

Researchers studied the effects of a 12-week exercise regimen on 148 active-duty Air Force airmen, half of whom also received a twice-daily nutrient beverage that included protein; the omega-3 fatty acid, DHA; lutein; phospholipids.

19 Oct 2020

A novel species of bacteria isolated from diseased walnut discovered in Portugal

Xanthomonas euroxanthea, a new species of bacteria isolated from diseased walnut discovered in Portugal.Bacteria recently isolated from walnut (Juglans regia L.) buds in Portugal has been identified as a new species of Xanthomonas.

19 Oct 2020

KNAUER subsidiary 'Das Labor. GmbH' produces SARS-CoV-2 antibody rapid tests in Africa

‘KNAUER Wissenschaftliche Geräte GmbH’ and its new subsidiary 'Das Labor. GmbH' produce reliable Corona antibody tests in Sub-Saharan Africa.

From KNAUER Wissenschaftliche Geräte GmbH 19 Oct 2020

CBD could reduce lung damage caused by COVID-19

One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation and whose levels are dramatically reduced in the face of this storm.

19 Oct 2020

Researchers study link between psychological responses and risk communication during COVID-19

The mental effects of pandemics on people can arise not only from the burden of preventive measures, the fear of contracting and cure but also coping with the exponential deaths.

19 Oct 2020

Scientists lay out a novel rationale for COVID-19 drug design

American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design - blocking a molecular "scissor" that the virus uses for virus production and to disable human proteins crucial to the immune response.

19 Oct 2020

New tool can provide non-invasive decision support for NSCLC treatment

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

16 Oct 2020

Adhesive plastic film inactivates novel coronavirus on contact

An adhesive plastic film designed to protect surfaces such as doorknobs, handrails, elevator buttons, and touch screens inactivates the novel coronavirus on contact.

16 Oct 2020

Scientists receive £265,000 to investigate link between vascular dementia and heart disease

Scientists from the University of Sheffield and University of Manchester have been awarded £265,000 from the British Heart Foundation, to investigate the links between vascular dementia and heart disease, and test whether a drug currently used to treat arthritis could also be used as a treatment for vascular dementia.

16 Oct 2020

Ziath to participate in two key virtual biobanking symposia

Ziath announce their participation in two key virtual symposia for scientists involved in biobanking - the ISBER Virtual Symposium 2020 and the Europe Biobank Week 2020.

From Ziath Ltd 16 Oct 2020

Antibody levels drop rapidly in recovering COVID-19 patients, shows study

In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients.

16 Oct 2020

People may be skeptical about medical and health articles on crowd-sourced websites

People may be skeptical about medical and health articles they encounter on crowdsourced websites, such as Wikipedia and Wikihealth, according to researchers.

16 Oct 2020

Scientists discover a novel antiviral strategy for treating COVID-19

A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, Department of Chemistry, Faculty of Science, and Professor Kwok Yung YUEN, Henry Fok Professor in Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKU), has discovered a novel antiviral strategy for treatment of COVID-19.

16 Oct 2020

Study sheds new light on how toxic PFAS chemicals spread from release sites

A study led by Brown University researchers sheds new light on how pollutants found in firefighting foams are distributed in water and surface soil at release sites.

16 Oct 2020

Synthetic signals could help control tissue regeneration, guide cellular therapies

For a tiny embryo to develop into an adult organism, its cells must develop in precise patterns and interact with their neighbors in carefully orchestrated ways.

16 Oct 2020

Glutathione precursor improves multiple deficits associated with premature aging

Premature aging in people with HIV is now recognized as a new, significant public health challenge. Accumulating evidence shows that people with HIV who are between 45 to 60 years old develop characteristics typically observed in people without HIV that are more than 70 years of age.

15 Oct 2020

Moffitt study uncovers how specific molecules promote cancer progression

The development of cancer is a highly complicated process, involving multiple genes and signaling pathways that become upregulated or downregulated throughout different stages of tumor growth and spread.

15 Oct 2020

Small molecule restores normal heart development in animal model with rare genetic disorder

A research team at the Greenwood Genetic Center has successfully used small molecules to restore normal heart and valve development in an animal model for Mucolipidosis II (ML II), a rare genetic disorder. Progressive heart disease is commonly associated with ML II.

15 Oct 2020

Laboratory News and Research

Oral antiseptics and mouthwashes may have the ability to neutralize human coronavirus

Health care groups dive into property tax ballot fight, eyeing public health money

Novel multimodal intervention improves physical fitness and cognitive function

A novel species of bacteria isolated from diseased walnut discovered in Portugal

KNAUER subsidiary 'Das Labor. GmbH' produces SARS-CoV-2 antibody rapid tests in Africa

CBD could reduce lung damage caused by COVID-19

Researchers study link between psychological responses and risk communication during COVID-19

Scientists lay out a novel rationale for COVID-19 drug design

New tool can provide non-invasive decision support for NSCLC treatment

Adhesive plastic film inactivates novel coronavirus on contact

Scientists receive £265,000 to investigate link between vascular dementia and heart disease

Ziath to participate in two key virtual biobanking symposia

Antibody levels drop rapidly in recovering COVID-19 patients, shows study

People may be skeptical about medical and health articles on crowd-sourced websites

Scientists discover a novel antiviral strategy for treating COVID-19

Study sheds new light on how toxic PFAS chemicals spread from release sites

Synthetic signals could help control tissue regeneration, guide cellular therapies

Glutathione precursor improves multiple deficits associated with premature aging

Moffitt study uncovers how specific molecules promote cancer progression

Small molecule restores normal heart development in animal model with rare genetic disorder

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo